FDA Import Refusal SCS-0867693-9/12/1 — SHREE PHARMA
The FDA refused shipment SCS-0867693-9/12/1 from SHREE PHARMA (India) on Jun 17, 2025. The refused product falls under Drugs and Biologics — TIRZEPATIDE (ANTI-DIABETIC). Cited charge: 75 This firm has 4 other import refusals on record.
Refusal Details
- Date
- Jun 17, 2025
- Country
- India
- Product Category
- Drugs and Biologics
- Product Code
- 61PDP74 TIRZEPATIDE (ANTI-DIABETIC)
- Charges
- 75